2 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of ACH24 in the Treatment of Vitiligo Group 01, Group 02 - Vitiligo | Phase 3 | Withdrawn | Ache Laboratorios Farmaceuticos S.A. | 2012-01-01 | 2016-03-16 | |
| Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo Melanocyte Keratinocyte transplantation - Vitiligo | Phase 2 / Phase 3 | Withdrawn | Henry Ford Health System | 2010-05-01 | 2017-03-10 |
Vitiligo (2)
Pigmentation Disorders (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
Ache Laboratorios Farmaceuticos S.A. (1) · Henry Ford Health System (1)
Brazil (1) · United States (1)